Clinical Trials Directory

Trials / Completed

CompletedNCT02762968

The Effects of Probiotic and HMB Supplementation on Immune and Digestive Function in Special Operations Soldiers

The Effects of 8-weeks of Probiotic and HMB Supplementation on Immune and Digestive Function in Special Operations Soldiers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
26 (actual)
Sponsor
Metabolic Technologies Inc. · Industry
Sex
All
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

The study will determine whether acute ingestion of a probiotic combined with beta-hydroxy-beta-methylbutyrate (HMB) can enhance immune and digestive function in soldiers during 8-weeks of advanced infantry training.

Detailed description

Up to sixty soldiers from an elite infantry unit will perform a parallel design investigation. Soldiers will be randomly assigned to one of four groups. Group 1 will consume the probiotic plus HMB, group 2 will consume HMB only, group 3 will consume only the probiotic, and group 4 will consume only placebo. All four groups will be garrisoned together, eat the same meals, and perform the same activity. All groups will be tested before as well as after an 8-week advanced infantry training program. During each testing session resting blood samples will be obtained to assess cytokine, inflammatory, and muscle damage markers. Additionally, questionnaires will be used to determine digestive health. Anthropometric, performance, and muscle volume measures will also be assessed prior to and immediately following the supplementation and training protocol.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPlaceboPlacebo capsules similar to the experimental treatments.
DIETARY_SUPPLEMENTHMBCapsules containing calcium HMB.
DIETARY_SUPPLEMENTBC30Bacillus Coagulans GBI-30, 6086 (BC30) mixed in water.

Timeline

Start date
2016-04-01
Primary completion
2016-07-01
Completion
2016-08-01
First posted
2016-05-05
Last updated
2017-01-30

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02762968. Inclusion in this directory is not an endorsement.